Preclinical development of T cell receptor gene therapy

被引:41
作者
Bendle, Gavin M. [1 ]
Haanen, John B. A. G. [2 ]
Schumacher, Ton N. M. [1 ]
机构
[1] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Div Med Oncol, NL-1066 CX Amsterdam, Netherlands
关键词
ENHANCED ANTITUMOR-ACTIVITY; TCR-ALPHA-BETA; IN-VIVO; CANCER REGRESSION; ANTILEUKEMIC REACTIVITY; TUMOR PROTECTION; SINGLE-CHAIN; LYMPHOCYTES; IMMUNOTHERAPY; ANTIGEN;
D O I
10.1016/j.coi.2009.02.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The adoptive transfer of TCR gene-modified T cells has been developed with the aim to induce immune reactivity toward defined tumor-associated antigens to which the endogenous T cell repertoire is non-responsive. Here we discuss in which areas preclinical studies in mouse models can or cannot be expected to be of value to guide clinical trial design, and how the available data from preclinical studies should influence forthcoming clinical trials.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 51 条
[1]   T-cell receptor gene therapy of established tumors in a murine melanoma model [J].
Abad, John D. ;
Wrzensinski, Claudia ;
Overwijk, Willem ;
De Witte, Moniek A. ;
Jorritsma, Annelies ;
Hsu, Cary ;
Gattinoni, Luca ;
Cohen, Cyrille J. ;
Paulos, Chrystal M. ;
Palmer, Douglas C. ;
Haanen, John B. A. G. ;
Schumacher, Ton N. M. ;
Rosenberg, Steven A. ;
Restifo, Nicholas P. ;
Morgan, Richard A. .
JOURNAL OF IMMUNOTHERAPY, 2008, 31 (01) :1-6
[2]   MHC multimer technology: current status and future prospects [J].
Bakker, AH ;
Schumacher, TNM .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (04) :428-433
[3]   Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes [J].
Bendle, GM ;
Holler, A ;
Pang, LK ;
Hsu, S ;
Krampera, M ;
Simpson, E ;
Stauss, HJ .
CANCER RESEARCH, 2004, 64 (21) :8052-8056
[4]   Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells [J].
Chamoto, K ;
Tsuji, T ;
Funamoto, H ;
Kosaka, A ;
Matsuzaki, J ;
Sato, T ;
Abe, H ;
Fujio, K ;
Yamamoto, K ;
Kitamura, T ;
Takeshima, T ;
Togashi, Y ;
Nishimura, T .
CANCER RESEARCH, 2004, 64 (01) :386-390
[5]   Long-term functionality of TCR-transduced T cells in vivo [J].
Coccoris, Miriam ;
Swart, Erwin ;
de Witte, Moniek A. ;
van Heijst, Jeroen W. J. ;
Haanen, John B. A. G. ;
Schepers, Koen ;
Schumacher, Ton N. M. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (10) :6536-6543
[6]   Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond [J].
Cohen, Cyrille J. ;
Li, Yong F. ;
El-Gamil, Mona ;
Robbins, Paul F. ;
Rosenberg, Steven A. ;
Morgan, Richard A. .
CANCER RESEARCH, 2007, 67 (08) :3898-3903
[7]   Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability [J].
Cohen, Cyrille J. ;
Zhao, Yangbing ;
Zheng, Zhili ;
Rosenberg, Steven A. ;
Morgan, Richard A. .
CANCER RESEARCH, 2006, 66 (17) :8878-8886
[8]   Requirements for effective antitumor responses of TCR transduced T cells [J].
de Witte, Moniek A. ;
Jorritsma, Annelies ;
Kaiser, Andrew ;
van den Boom, Marly D. ;
Dokter, Maarten ;
Bendle, Gavin M. ;
Haanen, John B. A. G. ;
Schumacher, Ton N. M. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (07) :5128-5136
[9]   TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation [J].
de Witte, Moniek A. ;
Bendle, Gavin M. ;
van den Boom, Marly D. ;
Coccoris, Miriam ;
Schell, Todd D. ;
Tevethia, Satvir S. ;
van Tinteren, Harm ;
Mesman, Elly M. ;
Song, Ji-Ying ;
Schumacher, Ton N. M. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (04) :2563-2571
[10]   An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease [J].
de Witte, Moniek A. ;
Jorritsma, Annelies ;
Swart, Erwin ;
Straathof, Karin C. ;
de Punder, Karin ;
Haanen, John B. A. G. ;
Rooney, Cliona M. ;
Schumacher, Ton N. M. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :6365-6373